78 related articles for article (PubMed ID: 2002982)
1. Antigen CA 19-9: presence in mucosa of nondiseased müllerian duct derivatives and marker for differentiation in their carcinomas.
Scharl A; Crombach G; Vierbuchen M; Göhring U; Göttert T; Holt JA
Obstet Gynecol; 1991 Apr; 77(4):580-5. PubMed ID: 2002982
[TBL] [Abstract][Full Text] [Related]
2. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube. I. Immunohistochemical detection.
Scharl A; Crombach G; Vierbuchen M; Müsch H; Bolte A
Arch Gynecol Obstet; 1989; 244(2):103-12. PubMed ID: 2712596
[TBL] [Abstract][Full Text] [Related]
3. CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and Fallopian tube. II. Immunoradiometric determination in secretions, tissue extracts and serum.
Crombach G; Scharl A; Würz H
Arch Gynecol Obstet; 1989; 244(2):113-22. PubMed ID: 2712597
[TBL] [Abstract][Full Text] [Related]
4. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.
Berchuck A; Soisson AP; Clarke-Pearson DL; Soper JT; Boyer CM; Kinney RB; McCarty KS; Bast RC
Cancer Res; 1989 Apr; 49(8):2091-5. PubMed ID: 2702650
[TBL] [Abstract][Full Text] [Related]
6. Tissue distribution of TAG-72 in malignant mixed müllerian tumors of the uterus.
Hackett TE; Kaminski P; Olt GJ; Zaino R; Podczaski E
Gynecol Oncol; 1994 Feb; 52(2):165-71. PubMed ID: 7508876
[TBL] [Abstract][Full Text] [Related]
7. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
8. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
9. The expression and localization of amylase in normal and malignant glands of the endometrium and endocervix.
Lee YS; Raju GC
J Pathol; 1988 Jul; 155(3):201-5. PubMed ID: 2457671
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.
Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS
Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336
[TBL] [Abstract][Full Text] [Related]
11. Thomsen-Friedenreich-related antigen in human endometrium. An immunohistochemical study employing the monoclonal antibody 49H.8. A preliminary report.
Ravn V; Jensen H
APMIS; 1988 Jun; 96(6):552-8. PubMed ID: 3293628
[TBL] [Abstract][Full Text] [Related]
12. Expression of IgA and secretory component in the normal and in adenocarcinomas of Fallopian tube, endometrium and endocervix.
Lee YS; Raju GC
Histopathology; 1988 Jul; 13(1):67-78. PubMed ID: 3209192
[TBL] [Abstract][Full Text] [Related]
13. Distribution of histo-blood group antigens in cervical and uterine endometrium.
Stubbe Teglbjaerg C; Ravn V; Mandel U; Dabelsteen E
APMIS Suppl; 1991; 23():100-6. PubMed ID: 1883633
[TBL] [Abstract][Full Text] [Related]
14. Tissue CA 125 and CA 19-9 in malignant, mixed mesodermal tumors of the uterus.
Podczaski E; Kaminski P; Hackett TE; Olt GJ; Zaino R
Gynecol Oncol; 1993 Apr; 49(1):56-60. PubMed ID: 8387061
[TBL] [Abstract][Full Text] [Related]
15. Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.
Susumu N; Kawakami H; Aoki D; Hirano H; Nozawa S
Cancer Res; 1993 Aug; 53(15):3643-8. PubMed ID: 8339270
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
Novakovic S; Fras PA; Jezersek-Novakovic B
In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
[TBL] [Abstract][Full Text] [Related]
17. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
19. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
[TBL] [Abstract][Full Text] [Related]
20. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
